CBB
REGN icon

Citizens Business Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Citizens Business Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.71M Sell
6,090
-92
-1% -$70.4K 0.77% 43
2025
Q4 		$4.77M Buy
6,182
+63
+1% +$42.8K 0.79% 42
2025
Q3 		$3.44M Sell
6,119
-6
-0.1% -$3.39K 0.57% 52
2025
Q2 		$3.22M Buy
6,125
+114
+2% +$63.6K 0.62% 48
2025
Q1 		$3.81M Buy
+6,011
New +$4.13M 0.83% 41

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Citizens Business Bank's REGN Position: Q1 2026 in Review

Citizens Business Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q1 2026, selling an estimated $70.4K and leaving 6,090 shares worth $4.71M. The position accounts for 0.77% of the portfolio, ranked #43.

Citizens Business Bank first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.77M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Citizens Business Bank held 6,090 shares of Regeneron Pharmaceuticals worth $4.71M as of Q1 2026.
  • Citizens Business Bank sold 92 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $70.4K.
  • Regeneron Pharmaceuticals made up 0.77% of Citizens Business Bank's portfolio in Q1 2026, its #43 holding.
  • Citizens Business Bank first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Citizens Business Bank's Regeneron Pharmaceuticals position peaked at $4.77M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Citizens Business Bank's 13F filing for Q1 2026, filed 1 May 2026.